原发性多汗症治疗进展

Treatment of primary hyperhidrosis

原发性多汗症是一种不符合人体正常体温调节、出汗过多，并影响患者生活质量的慢性疾病。普通人群中患病率为2.8% ~ 16.3%。原发性多汗症的治疗分为保守治疗和手术治疗。保守治疗包括局部止汗剂、抗胆碱能药物、电离子渗透疗法、肉毒素局部注射和激光、射频等。手术治疗主要包括腋窝汗腺的切除术、腋下吸脂术和交感神经切除术等。治疗应根据患者的自身情况，采用个体化治疗，其要点应按照保守治疗到手术治疗的原则进行。

Primary hyperhidrosis （PH） is a chronic disease characterized by abnormally increased sweating in excess of normal physiologic needs of the body, and severely affects the quality of life in patients. The incidence of PH ranges from 2.8% to 16.3% in the general population. Its treatment includes conservative therapy and surgical therapy. Conservative therapy of PH involves topical antiperspirants, oral anticholinergics, ionotherapy, botulinum toxin injection, lasers, radio frequency, etc. Surgical therapy involves excision of axillary sweat glands, axillary liposuction and sympathectomy. Individualized treatment is recommended for PH. Surgical therapy should be reserved for patients who fail to respond to conservative therapy.